TrialJournal of clinical pharmacology2014

Pharmacokinetics of dalfampridine extended release 7.5-mg tablets in healthy subjects and individuals with mild and moderate renal impairment: an open-label study.

Emil Samara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.